Revelation Biosciences (NASDAQ:REVB) announced on Tuesday that the company will implement a 1-for-3 reverse split of its common stock on July 7, 2025.
The company said the reverse stock split is intended to increase the market price per share of its common stock to regain compliance with Nasdaq's minimum bid continued listing requirement.